No Data
No Data
dian diagnostics group (300244.SZ) interim options equity distribution: 6.5 yuan per 10 shares
dian diagnostics group (300244.SZ) announced that the company's mid-year options distribution plan for 2024 is: based on the company's current...
dian diagnostics group (300244.SZ): has repurchased 2.14% of shares accumulated.
Dian Diagnostics Group (300244.SZ) announced that as of August 31, 2024, the company has repurchased a total of 13,406,000 shares through a designated securities account in the form of centralized bidding trading, accounting for 2.14% of the current total share capital. The highest fill price was ¥18.91 per share, and the lowest fill price was ¥11.64 per share. The total fill amount was ¥0.194 billion yuan (excluding transaction fees).
Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Dian Diagnostics Group: Half-year report for the year 2024.
Dian Diagnostics Group: Summary of Half-Year Report in 2024.
Dian Diagnostics Group (300244.SZ): Net income for the first half of the year was 71.7468 million yuan, a year-on-year decrease of 84.17%.
Dian Diagnostics Group (300244.SZ) announced its semi-annual report for 2024, with total operating revenue of 6.218 billion yuan, a year-on-year decrease of 9.12%; net income attributable to shareholders of the listed company is 71.7468 million yuan, a year-on-year decrease of 84.17%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses is 75.2674 million yuan, a year-on-year decrease of 77.34%; basic earnings per share of 0.1153 yuan.
No Data
No Data